Kolon Life (Korea) Investor Sentiment

102940 Stock  KRW 18,000  200.00  1.12%   
About 51% of Kolon Life's investor base is interested to short. The analysis of current outlook of investing in Kolon Life Science suggests that many traders are impartial regarding Kolon Life's prospects. The current market sentiment, together with Kolon Life's historical and current headlines, can help investors time the market. In addition, many technical investors use Kolon Life Science stock news signals to limit their universe of possible portfolio assets.
  
few days ago at news.google.com         
Teladoc Health Inc Quote - Press Release - The Globe and Mail
Google News at Macroaxis
over three months ago at news.google.com         
Pipeline Moves Novartis terminates Phase II ALS trial after benefit-risk worry - Clinical Trials Are...
Google News at Macroaxis
over three months ago at news.google.com         
KOLON Biotech Participates in BIO Asia-Taiwan 2024 from July 25 - PR Newswire
Google News at Macroaxis
over three months ago at news.google.com         
Kolon Life Science Inc.s biggest owners are retail investors who got richer after stock soared 25 pe...
Google News at Macroaxis
over three months ago at news.google.com         
Kolon Biotech, Inc. announced that it expects to receive KRW 3.604 billion in funding from Kolon Lif...
Google News at Macroaxis
over six months ago at news.google.com         
Nature Cell Keeps Hopes Up For JointStem Despite Conditional Approval Rejection - Scrip
Google News at Macroaxis
over six months ago at news.google.com         
Kolon Life Science Full Year 2023 Earnings 2944 loss per share - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Kolon Life Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 - Markets...
Google News at Macroaxis
over six months ago at news.google.com         
Kolon Biotech, Inc. announced that it has received KRW 2.001 billion in funding from Kolon Life Scie...
Google News at Macroaxis
over six months ago at news.google.com         
Risks Still Elevated At These Prices As Kolon Life Science Inc. Shares Dive 26 percent - Simply Wall...
Google News at Macroaxis
over six months ago at news.google.com         
Kolon Life Science Loses Appeal against Revocation of License for Invossa - BusinessKorea
Google News at Macroaxis
over a year ago at news.google.com         
Kolon Life Sciences gene therapy Invossa linked to 90 tumor cases regulator - KBR
Google News at Macroaxis
over a year ago at news.google.com         
Kolon Industries invests 18 million in resin factory for EV tires - The Korea JoongAng Daily
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Kolon Life that are available to investors today. That information is available publicly through Kolon media outlets and privately through word of mouth or via Kolon internal channels. However, regardless of the origin, that massive amount of Kolon data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Kolon Life news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Kolon Life relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Kolon Life's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Kolon Life alpha.

Kolon Life Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Kolon Stock analysis

When running Kolon Life's price analysis, check to measure Kolon Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kolon Life is operating at the current time. Most of Kolon Life's value examination focuses on studying past and present price action to predict the probability of Kolon Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kolon Life's price. Additionally, you may evaluate how the addition of Kolon Life to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
CEOs Directory
Screen CEOs from public companies around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Valuation
Check real value of public entities based on technical and fundamental data
FinTech Suite
Use AI to screen and filter profitable investment opportunities